Tessera Therapeutics
Megan Stellakis has a diverse work experience spanning several companies. In their current role as Head of HRIS at Tessera Therapeutics since 2022, they likely oversees the implementation and management of the company's HRIS system. Prior to joining Tessera Therapeutics, Megan worked at AIG for a significant period. Their roles at AIG included Global Head of HR Shared Services from 2020 to 2022, Director of Operations, Global HR Shared Services from 2018 to 2021, and Senior Manager HR Shared Services Operations from 2008 to 2018. In these positions, they managed HR shared services projects and process migrations, implemented process improvements, and collaborated with HR Centers of Excellence and the L&R Business on strategic HR projects. Megan's earlier experience includes a role as Senior Staffing Supervisor at Kelly Services from 2006 to 2008.
Megan Stellakis earned a Bachelor of Science degree in Hotel and Restaurant Management from the University of Houston, completing their studies from 1997 to 2000.
This person is not in any offices
Tessera Therapeutics
3 followers
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.